Giant Group International Patent, Trademark & Law Office

In the Giant Group, our biomedical team observes and analyzes domestic/international (major countries or regions) biomedical laws and regulations regularly for t heir latest trend to assist our clients in speeding up t heir search for related laws and regulations prior to new product development and marketing and cutting their incurred costs. To serve clients confused b y legal compliance or mystified by management issues, our biomedical team provides the clients with comprehensive services, such as giving professional advice to the client s and seeking advice from domestic competent authorities on
behalf of the clients, thereby assisting the clients in solving problems.

Gwo Xi Stem Cell Applied Technology Co., Ltd.

Gwo Xi Stem Cell Company has established the R&D center for cell therapy development since 2011. We are committed to developing stem cell medicines that have the potential to help patients with unmet medical needs. Our production platform fully comply with medical regulations (Good Tissue Practice, GTP) in Taiwan. We have three clinical trials are ongoing in Taiwan, and one clinical trial is ongoing in Vietnam by now. In the future, we will have established the PIC/S GMP grade stem cell preparation factory (15,225 m2 built-out space) in Hsinchu Biomedical Science Park in Taiwan to put stem cell-based medicinal products into practice.

H.P.B. HI-TECH CORP.

Combining AI image recognition and PPS (privacy protection system) technology, Ezcaring P1 provides the elderly with a high-quality life. It offers the safest, and effective care plan for sensitive areas such as home care, long-term care institutions, and medical institutions.
It has 5 main functions: Behavior analysis/ Sleep analysis/ Fall prevention/ Residence monitoring/ Emergency notification.
Caring for the Elderly with Dignity and Privacy.
PPS technology only detects changes in light and shadow generated by the movement of objects. It can be installed in the bedroom or bathroom without concern for invasion of privacy.

Hualien Tzu Chi Medical Center

Tzu Chi Charity Foundation had set foot around the world in over 122 countries. Therefore, Hualien Tzu Chi Hospital already became an internationalized medical center, which has accumulated many fruitful accomplishments over 37 years in medical aspects. For many years, it collaborated with charity, education, culture main missions and continued to provide innovation and hope within the Taiwan medical systems. Hence, our hospital participates in this exhibition with co-development firms. Our central theme this year is ”Stem cell innovative therapy” followed with other hot issues, including cell therapy, cancer immune treatment, development of new drugs and innovative medical appliances, smart healthcare, preventive medicine, international healthcare, and New Southbound Projects. We hope to share our accomplishments with society. Through this exhibition, our hospital wishes to enhance international links and achieve the initial intention of innovative development with people-oriented thoughts in the end.

Joint Commission of Taiwan

Joint Commission of Taiwan (JCT) is an independent, non-profit exclusive external accreditation body accredited by the International Society for Quality in Health Care (ISQua). JCT provides a resource-sharing platform for healthcare partners through accreditation, quality improvement activities, and medical education.

JCT established the Health Smart Taiwan (HST), a one-stop portal designed catalyze the existing digital solutions scalable through offering a wide range of consultations, workshops, campaign, acceleration services and piloting projects in hospitals. It provides integrated services for healthcare institutions to achieve digital transformation, shaping a quality, safe, and efficient healthcare environment.

In this exhibition, HST will show the special theme-"Innovative Technology in Medical Professional Training". You will learn more immersive training combined with virtual reality, and interactive training such as game-based learning, simulation training, etc.

Kaohsiung Veterans General Hospital

smart medication

National Taiwan University

National Taiwan University and National Taiwan University Hospital will exhibit the advanced technique and solutions.

National Taiwan University Hospital

Shine-On BioMedical Co.,Ltd.

SOA101 Nano Tri-specific Dual Immune Checkpoint Antibody • The only triple-specific antibody targeting dual immune checkpoints on cancer cells in Asia. • Highly specific cancer-targeting PD-L1 & HLA-G dual immune checkpoint antibodies can overcome the tumor heterogeneity, reduce drug resistance, and improve therapeutic effectiveness. • The “Next generation” drug for various solid tumors therapy. SOA201 EphA10 Tri-specific T cell Engager • Tri-specific antibody targets dual immune cells. • The EphA10 tumor antigen is highly expressed in TNBC (almost negligible expression in normal cells), providing high safety and provides the solution for unmet medical need of TNBC about lacking targeted drug therapy. • Enhancing anti-cancer efficacy by T cells and NK cells activation. • The “Next generation” drug for various solid tumors therapy. SOB101 Drug Payloads Engineered Exosomes • The only anti-cancer exosome drug targeting HLA-G in Asia. • Engineering exosomes with anti-HLA-G bind to tumor cells specifically, effectively reducing the dosage of chemotherapy drugs. • Multiple drug payloads for cancer therapy. • The “Next generation” drug for various solid tumors therapy. SOB102 Novel Anti-Cancer Exosomal Nucleic Acid Drug • Targeting HLA-G, deliver the carried nucleic acid and chemotherapy drugs to the tumor effectively and safely. • Blood-brain barrier (BBB) crossable and solve the clinical treatment dilemma of drug-resistant glioblastoma multiforme (GBM).

TAIPEI MEDICAL UNIVERSITY

Established in 1960, over the past century, Taipei Medical University underwent the process of continuous expansion, transformation and innovation. Today, TMU has expanded into a world-class university with 11 Colleges and 1 General Education Center, 6000 students per year, 47,000 alumni around Medical Academic Institute, Medical Industry and six affiliated hospitals which are TMU hospital, Wan Fang Hospital, Shuang Ho Hospital, Hsin Kuo Min Hospital, Tapei Cancer Center and Taipei Neuroscience Institute.
Based on the core value of humanistic empathy, honesty and integrity, innovation, teamwork and social service, TMU is dedicated to excellent teaching, outstanding research, industry-academia collaboration, international participation and social service, in order to integrate clinical resource of affiliated hospitals and meet the visions of translation medicine innovation, biomedical industry development, research advancement and positive social influence. 3 main strategies of future development are below.